How BDX Has Actually Traded Around Earnings
BDX has delivered an 8/8 beat rate over the last eight reported quarters, with an average earnings surprise of 8.6%. That is a clean run of outperformance, and the average 5-day price move in the five trading days after those reports is +3.95%, classified as an upward drift. Yet the more instructive detail is that the post-earnings drift has not reliably followed the direction of the surprise. In other words, beating the estimate has not guaranteed a follow-through move higher.
The last four reports make the disconnect concrete. On May 7, 2026, BDX reported EPS of $2.90 against an estimate of $2.78, a 4.3% positive surprise, but the stock fell 2.5% the next day and 5.74% over the next five sessions. By contrast, the February 9, 2026 report produced a 31.7% surprise ($2.91 vs. $2.21 estimate) and a 5.3% next-day gain that extended to 8.8% over five days. The November 6, 2025 quarter was a 1% beat ($3.96 vs. $3.92) that produced only a 0.25% next-day move yet finished the week up 8.82%. The August 7, 2025 report delivered an 8.2% beat ($3.68 vs. $3.40) and behaved more conventionally, with a 3.1% next-day gain and 3.9% five-day gain. The average is positive because of the magnitude of a few winners, not because every beat delivered a linear result.
Options Flow and the August 6 Catalyst
BDX is scheduled to report next on August 6, 2026 before the open, with the consensus EPS estimate at $3.14. Heading into that print, options flow reflects two competing forces: the headline beat streak and the May 2026 example, where a beat preceded a negative five-day drift. Implied volatility rises into the event as standard pre-earnings behavior, with the market pricing in a move based on realized post-earnings ranges.
Positioning clusters around the unofficial consensus rather than the stated analyst number. If the options market prices a larger implied move than the realized average of 3.95%, traders are treating the report as carrying above-average event risk. If implied volatility suggests a smaller priced-in move, the flow may be implying mean reversion. Either way, the May 2026 response is a reminder that the magnitude of the beat has not been the dominant driver of the post-earnings price path.
What a Disciplined Trader Watches For
A disciplined approach to BDX around the August 6 report starts with the recognition that 100% beat rate does not equal 100% upside follow-through. The average 5-day drift of +3.95% is useful context, but the dispersion—from -5.74% to +8.82%—is what matters for risk sizing. The current snapshot shows BDX at $156.36, with RSI at 55.9 and the 50-day EMA at $151.98. Whether the stock is above or below that moving average heading into the print helps frame short-term reference levels without predicting direction.
Traders also watch whether the stock has already run up into earnings, because a strong pre-event move can compress upside even if the headline number exceeds $3.14. Sector strength in Healthcare/Medical - Instruments & Supplies and any commentary around margins, FX, or guidance can shift how the same numerical beat is received. For a deeper dive into how institutions are positioned and what they expect from the full August 6 quarter, the reader should look at the full institutional verdict on the ticker.
Frequently Asked Questions
What is BDX's earnings beat rate and average surprise over the last eight quarters?
BDX has beaten in all of the last eight reported quarters, an 8/8 record, with an average earnings surprise of 8.6%.
Why did BDX fall after its May 7, 2026 earnings beat?
On May 7, 2026, BDX reported EPS of $2.90 versus an estimate of $2.78, a 4.3% positive surprise, yet the stock declined 2.5% the next day and 5.74% over the following five trading sessions.
When is BDX's next earnings report and what is the consensus EPS estimate?
BDX's next scheduled earnings release is August 6, 2026 before the market open, with a consensus EPS estimate of $3.14.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-05-07 | $2.9 | $2.78 | +4.3% | -2.5% | -5.74% |
| 2026-02-09 | $2.91 | $2.21 | +31.7% | +5.3% | +8.8% |
| 2025-11-06 | $3.96 | $3.92 | +1% | +0.25% | +8.82% |
| 2025-08-07 | $3.68 | $3.4 | +8.2% | +3.1% | +3.9% |
| 2025-05-01 | $3.35 | $3.28 | +2.1% | - | - |
| 2025-02-05 | $3.43 | $3 | +14.3% | - | - |
Previous BDX editions
Get the institutional verdict on BDX
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the BDX verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.